NorthRock Partners LLC Buys Shares of 10,290,049 Envoy Medical, Inc. $COCH

NorthRock Partners LLC bought a new stake in shares of Envoy Medical, Inc. (NASDAQ:COCH) in the second quarter, Holdings Channel reports. The fund bought 10,290,049 shares of the company’s stock, valued at approximately $14,612,000. NorthRock Partners LLC owned 0.48% of Envoy Medical at the end of the most recent reporting period.

Separately, Arcus Capital Partners LLC purchased a new stake in shares of Envoy Medical during the first quarter valued at approximately $244,000. 8.59% of the stock is currently owned by institutional investors.

Envoy Medical Trading Down 6.8%

Shares of COCH stock opened at $0.89 on Monday. Envoy Medical, Inc. has a 12-month low of $0.74 and a 12-month high of $3.09. The firm’s 50 day moving average is $1.20 and its 200 day moving average is $1.38. The stock has a market capitalization of $21.07 million, a P/E ratio of -0.62 and a beta of 2.09.

Envoy Medical (NASDAQ:COCH) last issued its earnings results on Thursday, July 31st. The company reported ($0.32) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.29) by ($0.03). The company had revenue of $0.08 million for the quarter, compared to the consensus estimate of $0.07 million. As a group, equities analysts predict that Envoy Medical, Inc. will post -1.21 earnings per share for the current year.

Analysts Set New Price Targets

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Envoy Medical in a report on Wednesday, October 8th. Two equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $9.25.

About Envoy Medical

Envoy Medical, Inc, a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc in September 2023.